The stock prices for Fisher and Paykel increased from 2.13 at the end of February to 2.26 on the march 7th. The reason for this sharp increase in price is Fisher & Paykel Healthcare Corporation Limited announced a three-year renewal of their longstanding agreement providing CareFusion the exclusive right to distribute Fisher & Paykel Healthcare products into the U.S. hospital market. Based on the this new announcement and previous trends I believe the stock price will remain relatively constant for the next 6-12 months before another sharp change in price as it as happened before.
No comments:
Post a Comment